457614-00-5

Upstream product

• 457613-99-9 (3R,4S)-1-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-6-[(tert-butyldiphenylsilyl)oxy]-4-(4-methoxyphenoxy)hexan-3-ol 
• 144090-56-2 2,2-dimethyl-3-<(1,1-dimethylethoxy)carbonyl>-4(S)-oxazolidinepropanal 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 457613-95-5 (3R,4S)-1-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-4-(4-methoxyphenoxy)hex-5-en-3-ol 
• 457613-98-8 (3S,4R)-6-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-3-(4-methoxyphenoxy)hexan-1,4-diol 
• 457613-96-6 (3S,4R)-6-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-3-(4-methoxyphenoxy)-4-[(triethylsilyl)oxy]hex-1-ene 
• 13391-35-0 allyl (4-methoxyphenyl) ether 

Downstream Products

• 457614-01-6 (3S,4S)-4-azido-6-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-1-[(tert-butyldiphenylsilyl)oxy]hexan-3-ol 
• 20084-93-9 (1S,6S,8aS)-1-acetoxy-6-aminooctahydroindolizidine 
• 219663-40-8 ((1S,6S,8aS)-1-Hydroxy-octahydro-indolizin-6-yl)-carbamic acid tert-butyl ester 
• 457614-04-9 (1S,6S,8aS)-6-[(tert-butoxycarbonyl)amino]-1-benzyloxyoctahydroindolizidine 
• 457614-03-8 (2S,5S,6S)-5-azido-6-benzyloxy-2-[(tert-butoxycarbonyl)amino]octan-1,8-diol 
• 457614-07-2 (2S,5S,6S)-5-azido-6-benzyloxy-2-[(tert-butoxycarbonyl)amino]-1,8-[(methylsulfonyl)oxy]octane 
• 457614-02-7 (3S,4S)-3-azido-4-benzyloxy-1-[(4S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-6-[(tert-butyldiphenylsilyl)oxy]hexane 

Relevant academic research and scientific papers

Enantioselective allyltitanation. Synthesis of (-)-slaframine

An enantioselective synthesis of the indolizidine alkaloid (-)-slaframine from aldehyde 1 is reported. The stereogenic centers at C-1 and C-8a are introduced by an enantioselective allyltitanation and a Mitsunobu reaction. Reductive double cyclization of